Use Able AI chat for product recommendations

MLXIPL Polyclonal antibody

MLXIPL Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, IP, ELISA

ChREBP, BHLHD14, Carbohydrate-responsive element-binding protein, Class D basic helix-loop-helix protein 14, MIO

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for MLXIPL in ?

Tested Applications

Positive WB detected inmouse liver tissue, human liver tissue, HepG2 cells, HeLa cells, rat liver tissue
Positive IP detected inHepG2 cells
Positive IHC detected inhuman colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

13256-1-AP targets MLXIPL in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag3481

Product name: Recombinant human MLXIPL protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-350 aa of BC012925

Sequence: MAGALAGLAAGLQVPRVAPSPDSDSDTDSEDPSLRRSAGGLLRSQVIHSGHFMVSSPHSDSLPRRRDQEGSVGPSDFGPRSIDPTLTRLFECLSLAYSGKLVSPKWKNFKGLKLLCRDKIRLNNAIWRAWYIQYVKRRKSPVCGFVTPLQGPEADAHRKPEAVVLEGNYWKRRIELPPEDAYVGNADMIQPDLTPLQPSLDDFMDISDFFTNSRLPQPPMPSNFPEPPSFSPVVDSLFSSGTLGPEVPPASSAMTHLSGHSRLQARNSCPGPLDSSAFLSSDFLLPEDPKPRLPPPPVPPPLLHYPPPAKVPGLEPCPPPPFPPMAPPTALLQEEPLFSPRFPFPTVPPA

Predict reactive species
Full Name MLX interacting protein-like
Calculated Molecular Weight 852 aa, 93 kDa
Observed Molecular Weight 65 kDa
GenBank Accession NumberBC012925
Gene Symbol MLXIPL
Gene ID (NCBI) 51085
RRIDAB_2266665
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9NP71
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Carbohydrate response element-binding protein (ChREBP), also known as MLXIPL, is a glucose-responsive transcription factor that has a fundamental role in the glucose-mediated induction of genes involved in hepatic glycolysis and lipogenesis. Circulating blood glucose levels affect ChREBP activity in hepatocytes largely by post-translational mechanisms that include phosphorylation-dependent subcellular localization [PMID:21665952]. It enhances expression of the liver pyruvate kinase (LPK) gene and all lipogenic enzyme genes resulting in the conversion of excess dietary carbohydrate into triglycerides that can be stored as fat [PMID:15118080]. Molecular Weight of ChREBP splice variants: 62/78/91/93 kDa.

Protocols

Product Specific Protocols
IF protocol for MLXIPL antibody 13256-1-APDownload protocol
IHC protocol for MLXIPL antibody 13256-1-APDownload protocol
IP protocol for MLXIPL antibody 13256-1-APDownload protocol
WB protocol for MLXIPL antibody 13256-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The MLXIPL (ChREBP) Polyclonal antibody (Cat# 13256-1-AP) has 22 citations spanning journals including Science, Phytomedicine, Acta Pharmacol Sin, EMBO Rep, J Ethnopharmacol, Front Pharmacol, and Clin Transl Med. Research fields cover hepatic lipid metabolism, NAFLD/NASH, type 2 diabetes, fatty acid synthesis, vascular aging, atherosclerosis, obesity, alcohol-induced liver injury, and cancer progression.

SpeciesApplicationTitle

Science

Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling

Authors - Kaixin Ding
mouse,humanWB

Phytomedicine

Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis.

Authors - Xiangyu Chen
  • KD Validated
mouse,humanWB,IF

Acta Pharmacol Sin

6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice

Authors - Ke Gong
mouse,humanWB,IF

Acta Pharmacol Sin

Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway

Authors - Jian Lu
humanWB

Phytother Res

A Natural LDHA Allosteric Inhibitor Geraniin Suppresses Triple-Negative Breast Cancer Cell Growth.

Authors - Yan Yu
mouseWB,IHC

Clin Transl Med

Phosphoproteome reveals molecular mechanisms of aberrant rhythm in neurotransmitter-mediated islet hormone secretion in diabetic mice.

Authors - Yunqiang He

Reviews

    5.0 out of 5
Add a review

1 verified customer reviews

What customers say

The single review (5/5) was posted on December 17, 2025 by a researcher who used this antibody for Western Blot at a 1:1000 dilution on human adipocyte cells. They confirmed that knockout cells showed no MLXIPL expression, demonstrating the antibody's high specificity and reliability for detecting the target protein.

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


ILKNUR (Verified Customer) (12-17-2025)

The knock out cells show no expression of MLXIPL

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:1000
  • Cell Tissue Type: HUMAN ADIPOCYTE CELLS
MLXIPL Antibody Western Blot validation (1:1000 dilution) in HUMAN ADIPOCYTE CELLS (Cat no:13256-1-AP)
Loading...
||
New chat

Able™

正在加载,请稍候...